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Interferon gamma  release assay
a  b  s  t  r  a  c  t
Johne’s  disease  (JD),  or  paratuberculosis  is  a  fatal  enteritis  of  animals  caused  by  infec-
tion with  Mycobacterium  avium  subspecies  paratuberculosis  (Map).  There  may  be a long
subclinical  phase  with  no  signs  of  clinical  disease.
Diagnosis  of  JD  is problematic  and  no  test  can reliably  detect  sub-clinical  disease.  Th1
responses  to  Map  are  believed  to be activated  first with  a  later  switch  to Th2  responses
and  progression  to  clinical  disease.  Detection  of a cell-mediated  response,  indicated  by
interferon  gamma  (IFN-)  produced  in  response  to  mycobacterial  antigens,  may  give an
early indication  of  infection.  Crude  extracts  of  Map (PPDj)  have  been  used  to detect  the
cell-mediated  response,  but  more  specific,  quantifiable  antigens  would  improve  the  test.
Thirty Map-specific  proteins  were  screened  for their  ability  to  raise  a cell-mediated
response  in  subclinically  infected  sheep.  Four  proteins  were  selected  and  tested  using  blood
from  subclinical  animals  and  controls  from  a JD-free  flock.  Three  proteins  elicited  IFN-
levels  which  were  higher  in  the  subclinical  group  than  in the  control  group,  two  were  sta-
tistically significant.  Thus  these  proteins  have  the  ability  to discriminate  groups  of infected
and  uninfected  animals  and  may  have  use in  diagnosis  of  JD.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Johne’s disease (JD), or paratuberculosis, is a fatal,
chronic granulomatous enteritis of animals caused by
Mycobacterium avium subspecies paratuberculosis (Map),
characterised by severe emaciation, poor body condition
and in some species diarrhoea. The disease is mainly spread
through ingestion of contaminated faecal material and
following infection, a long incubation period may  ensue
Abbreviations: JD, Johne’s disease; IGRA, interferon gamma  release
assay.
∗ Corresponding author. Tel.: +44 (0)131 445 5111;
fax: +44 (0)131 445 6111.
E-mail address: Val.Hughes@moredun.ac.uk (V. Hughes).
during which there are no signs of clinical disease. These
subclinical animals may  go undetected and infect their
herd-mates before clinical symptoms become apparent
(Sweeney et al., 1992; Chiodini, 1996; Toman et al., 2003).
The diagnosis of JD is problematic and no test can
reliably detect subclinical disease. Subclinical animals are
particularly difficult to diagnose, they may  be shedding
small numbers of Map  in their faeces intermittently and
levels of circulating antibodies against Map may  be low and
not detectable by ELISA tests. PCR detection or bacteriolog-
ical culture of faeces may  not be sufficiently sensitive to
detect low levels of organisms or may  miss intermittent
shedders. Thus control programmes are hampered by the
inability to detect subclinical animals which fall below the
radar of currently available tests.
0165-2427/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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Early detection of Map  infection is desirable to lessen
the risks of transmission. The classical switch profile has
been described for the immunological response of animals
to Map  infection (Chiodini et al., 1984; Stabel, 2000, 2006),
in which Th1 responses are the first to be activated. Thus
detection of a cell-mediated immune response by mea-
suring the levels of interferon gamma  (IFN-) produced
in response to mycobacterial antigens (often PPD) (Wood
et al., 1989) may  give an early indication of subclinical
animals and may  occur before faecal shedding or anti-
bodies directed against Map  can be detected (Benedixen,
1978; Chiodini, 1996). A drawback to the IFN- test, which
is the requirement for fresh blood samples, has recently
been overcome by the addition of preservatives (IL-7, IL-
12 and anti-IL-10), which allows a lengthened time period
between collection and assay (Plain et al., 2012; Mikkelsen
et al., 2012).
PPDj is a crude extract of Map  and contains many
antigenic components shared with the closely related envi-
ronmental organism M.  avium subspecies avium and with
other pathogenic mycobacteria including M.  bovis. Thus use
of PPDj has issues for quality control and specificity. Sub-
stitution of PPD by specific recombinant proteins would
greatly enhance the confidence in this test to diagnose Map
infection and allow definition and quantification of anti-
gen in the assay. Recently, Map  recombinant proteins have
been used to improve the specificity of the response in cat-
tle (Mikkelsen et al., 2011). Here we describe a study to
determine the efficacy of different Map  recombinant pro-
teins to elicit a Th1 response in naturally exposed sheep
obtained from a flock with a history of JD and identify three
recombinant proteins, which may  have the ability to detect
early Map  infection when incorporated into an interferon
gamma  release assay (IGRA).
2. Materials and methods
2.1. Selection of subclinically infected animals
Subclinically infected animals were selected from two
farms. Farm A had a high prevalence of ovine JD, with 27
clinical cases diagnosed between 2002 and 2008. Of these,
22 were classified as paucibacillary and the remainder as
multibacillary disease following histopathological exami-
nation. Farm B had a low prevalence of JD with only one
clinical case confirmed by tissue culture over the same
period. The flocks on the farms were screened using the
BovigamTM (Celtic Diagnostics Ltd, Dublin, Ireland) IGRA.
Whole blood was stimulated with PPDj and incubated for
24 h and the IGRA was performed. Animals producing more
than 400 pg/ml of IFN- were considered responders and
subclinically infected. These animals did not show any
clinical signs of JD and were transported to the Moredun
Research Institute where they were housed until the end
of the study.
2.2. Selection of control animals
Control animals were sourced from Farm C with no his-
tory of clinical JD. Animals were negative in the following
tests: BovigamTM IGRA, JD serum ELISA and faecal culture.
2.3. Blood collection from sheep
Blood was collected by venipuncture in vacutainer
tubes (those for IGRA contained preservative-free heparin).
Experimental procedures were assessed and approved by
an Experiments and Ethics Committee and authorised
under the Animals (Scientific Procedures) Act 1986.
2.4. Preparation of PBMCs
PBMCs were prepared from buffey coat of heparinised
blood using lymphoprep (Nycomed). Residual erythro-
cytes were removed by hypotonic lysis. PBMCs were
suspended in RPMI complete (RPMI 1640 [84%, v/v],
foetal bovine serum [10%, v/v], glutamine [1 mM], peni-
cillin [100 U/ml], streptomycin [100 g/ml], gentamycin
[100 g/ml], -mercapto ethanol [50 M],  sodium bicar-
bonate [0.08%, w/v], HEPES [25 mM]), counted and adjusted
to 2 × 106 cells per ml.
2.5. Incubation of blood with antigen
Whole blood (750 l) or 500 l of PBMCs, were
incubated with either PPDa (purchased from AHVLA Wey-
bridge), PPDj or purified recombinant protein added in
a volume of 50 l to a final concentration of 2.5, 2.5 or
10 g/ml, respectively. ConA or SEB (final concentrations
of 5 or 1 g/ml, respectively) were used as stimulation
controls, media controls (either RPMI or PBS) were also
included. Stimulated blood was  incubated in 5% (v/v) CO2
for 24 h, centrifuged (500 g, 5 min  at room temperature)
and approx 500 l supernatant removed and stored at
−70 ◦C until required.
2.6. BovigamTM IFN- release assay
The IGRAs were performed as described by the manufac-
turer. Ovine IFN- standards ranging from 0 to 5000 pg/ml
were assayed on each plate analysed. This data enabled
calculation of the amount of IFN- released during the
stimulation. Alternatively, ODs were calibrated according
to the OD-values of the positive and negative controls on
the respective plates as described previously (Jungersen
et al., 2002).
2.7. JD antibody ELISA test
Blood samples were commercially tested for serum
antibody (Biobest Midlothian, UK) using the JD ELISA test
(Institute Pourquier, Montpellier, France).
2.8. Preparation of recombinant proteins
Thirty recombinant Map proteins, previously identified
as potentially Map-specific were tested. Maltose Binding
Protein (MBP)-fusion recombinant proteins were cloned
and purified (Hughes et al., 2008). Protein solutions were
either diluted in RPMI complete for PBMC stimulation or
PBS for whole blood stimulations.
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2.9. Post mortem and histopathology
Animals were euthanized with an intravenous injec-
tion of 100 mg/kg pentobarbital. Samples of ileum, distal
jejunum (DJ), mesenteric lymph node (MLN), ileo-caecal
valve (ICV) and ileo-caecal lymph node (ICLN) were col-
lected, and fixed in 10% buffered formalin saline to be
processed for histology. Samples of MLN, terminal ileum
(TI) and ICLN were removed for bacteriological culture.
Microscopical examination was performed on paraffin-
wax embedded, 5 m-thick sections mounted on glass
microscope slides and stained with haematoxylin and
eosin (H&E) and Ziehl–Neelsen staining (ZN) for acid-fast
bacteria. Animals were classified as paucibacillary or multi-
bacillary according to the criteria described by Clarke and
Little (1996).
2.10. Bacteriological culture from post mortem tissues
Tissue sections (either fresh or previously frozen
at −80 ◦C) were trimmed of fat and connective tis-
sue, homogenised, decontaminated and used to inoc-
ulate slopes of Middlebrook 7H11 supplemented with
mycobactin J as described previously (Hughes et al., 2007).
MLN  and TI were submitted for bacteriological culture for
all animals, ICLN was also submitted from W363, PC212, P7
and 4349.
2.11. Bioinformatics
Kyoto encyclopedia of genes and genomes (KEGG) was
used to retrieve gene sequences. The SOSUI system for clas-
sification and secondary structure prediction was  used to
determine the likelihood of these proteins being mem-
brane associated (Hirokawa et al., 1998).
2.12. Statistical analysis
Because of the small number of observations per ani-
mal  and the presence of heterogeneity in variance of the
status of animal, a linear model using generalised least-
squares was fitted to the OD data. The infection status of
animals, recombinant protein and the interaction of these
factors were fitted as categorical fixed effects. The hetero-
geneity in variance associated with the status of animal was
explicitly modelled. The estimate of the residual variance
component was obtained by the Restricted Maximum Like-
lihood (REML) method (Pinheiro and Bates, 2000). To take
into account the multiple comparisons of several proteins,
the p-values estimated under the fitted model for each pair-
wise comparison were adjusted so that the overall false
discovery rate was 5% (Benjamini and Hochberg, 1995). All
statistical analyses were carried out using the R software
version 2.13.1 (R Core Team, 2012).
3. Results and discussion
Naturally infected flocks were utilised to establish a
panel of sheep identified by IGRA screening; selecting indi-
viduals with no clinical signs of disease but elevated IFN-
responses to PPDj. The assumption was that the selected
animals had been exposed to Map and were subclinically
infected. Thirty recombinant proteins were tested for their
ability to elicit IFN- production in PBMCs of nine subcli-
nical sheep, results are presented in Table 1.
Animals showing production of IFN- in excess of
50 pg/ml were deemed to have responded to the antigen.
Responses of animals to individual proteins varied consid-
erably, no two animals responded to the same subset. Of
the 30 recombinant Map proteins investigated, all were
deemed to elicit a IFN- response in at least one animal.
Some animals were particularly responsive to the protein
antigens whilst others had limited responses. Four proteins
(MAP1297, MAP1365, MAP3651c and MAP0268c), were
selected for further investigation primarily on the basis of
the number of animals exhibiting a response and its mag-
nitude.
The likelihood of the selected proteins being mem-
brane associated was  determined using the SOSUI
system, only MAP0268c was  indicated as membrane-
associated, and is a hypothetical protein with a thiopurine
S-methyltransferase motif. The other proteins were
predicted as soluble and annotated as phosphoribosyl
isomerise (MAP1297), ornithine carbamoyltransferase
(MAP1365) both involved in amino acid biosynthesis, and
FADE3 2 (MAP3651c) central to terpenoid and geraniol
metabolism. To assess the diagnostic potential of the
selected proteins, IFN- responses of subclinical and unin-
fected animals were compared. Six subclinical animals
from Farm A (P7, P33, W363, W395, PC212, 0269) and four
control animals (724A, 329A, 307A, and 463A) selected at
random from Farm C were used in this study. Whole blood
was used rather than PBMCs for the IGRA as this would be
the sample of choice for diagnostic testing. IGRAs on whole
blood were carried out in duplicate with the selected
proteins, MBP, and PPDa and data were analysed (Fig. 1A).
The mean OD value for each blood sample tested was
calibrated and corrected for the contribution of MBP  to the
stimulation. The data showed heterogeneity in variance
for the status of infection and it was noted that the OD
value of one of the animals in the infected group stimu-
lated with MAP0268c was  an order of magnitude higher
than the other comparable readings and considered an
outlier.
Statistical analysis of data following exclusion of the
outlier (observation on animal W363 for MAP0268c)
showed that the interaction effect of treatment group
and protein was statistically significant (p = 0.022) which
indicated that there was evidence of genuine differences
in mean responses between the control and subclinical
animal groups for some of the proteins. For all proteins,
mean levels were higher in the subclinical group and the
means were markedly different for MAP0268c, MAP1365
and MAP3651c. For the recombinant protein MAP3651c,
the mean OD value (±standard error of mean) of the
infected group (0.198 ± 0.035) was  statistically signifi-
cantly (false discovery rate-adjusted p = 0.010) higher than
the mean OD value of the control group (0.015 ± 0.043).
Additionally, for the protein MAP0268c, there was weak
evidence (FDR-adjusted p = 0.051) that the mean OD value
of the infected group (0.051 ± 0.017) was higher than the
mean OD value of the control group (−0.009 ± 0.019). The
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Table 1
IFN- responses to recombinant Map antigens in subclinical animals.
P7 P15 P33 W363 PC212 W395 O269 1707N 1585N Number of responders  
MAP0068 2 
MAP0139c / / 3 
MAP0268c / 6 
MAP0334 / ND 6 
MAP1012c / / / 5 
MAP1160c / / 3 
MAP1293 3 
MAP1297 ND  ND  6 
MAP1365 ND  ND  5 
MAP1564c / 4 
MAP1754c / 2 
MAP2541c / / / 4 
MAP2685 ND  ND  4 
MAP2872c / / 3 
MAP2878c ND  / 5 
MAP3175 ND  ND  5 
MAP3205  / 1 
MAP3385 / / / 4 
MAP3457  / 2 
MAP3491  / / / 4 
MAP3540c / 2 
MAP3567  / / 4 
MAP3627  / / 2 
MAP3651c / / / / 7 
MAP3692c ND 4 
MAP3841  / 1 
MAP3857 ND  ND  4 
MAP3932c ND  / 2 
MAP4147  / / / / 5 
MAP4233  / / 3 
< 50 pg
/ > 50 pg<100pg IFN-γ   
> 100pg IFN-γ   
ND  not determined 
Proteins which were selected for further investigation are highlighted.  
difference of the mean OD values of infected and control
groups for MAP1365 was short of statistical significance
(p = 0.16) and that for MAP1297 protein was also not
statistically significant.
Inclusion of the outlying data point vastly increased
the mean OD for the infected animal group but also
increased the observed variation and the observed effect
ceased to be statistically significant. Exclusion of the data
point is not unreasonable given that technical errors
in plate manipulation can lead to spurious high OD
readings.
During the period of recombinant antigen testing,
responses of animals to PPDj were also monitored and
the results are presented in Fig. 1B. All animals (except
P15) exhibited consistently high levels of IFN- produc-
tion in response to PPDj, although a degree of fluctuation
was  observed. Despite this fluctuation, most IGRA results
were in excess of the arbitrary 400 pg/ml cut off we had
applied in selecting the animals for investigation. Ani-
mal  P15 however, demonstrated the classical IFN-gamma
response pattern in JD (Stabel, 2000), in that it responded
highly to PPDj in the subclinical stage (day 1-levels in
excess of 500 pg ml−1), but the response was  lost rapidly
after transport to Moredun (0–5 pg ml−1) where it rapidly
succumbed to JD 30 days after purchase.
Subclinical animals were monitored (up to 4 years)
for IFN- responses to PPDj and ELISA tests were per-
formed periodically for detection of Map antibodies. Over
the course of the experiment, four animals were found to
have a positive JD antibody ELISA test (P15, PC212, P7 and
4349). Results of the repeated ELISA tests can be found in
supplementary Table S1.
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Fig. 1. (A) Mean OD values of infected and non-infected animals generated in BovigamTM IFN- release assays. Whole blood was stimulated with four
recombinant antigens (MAP268c, MAP1297, MAP1365 and MAP3651c). The infected group comprised six animals sourced from a paratuberculosis-infected
flock  the control group comprised four animals sourced from a flock with no history of paratuberculosis. The data was calibrated and corrected for the
contribution of MBP  and medium to the stimulation. The error bar indicates the standard error of mean. (B) Temporal changes in IFN- production of
whole  blood from nine subclinical sheep in response to PPDj. OD values were generated in BovigamTM IFN- release assays. Nine animals (P7, p15, P33,
W363,  PC2121, W395, O269, 1707N, 1585N) sourced from paratuberculosis-infected farms were monitored periodically. The data was corrected for the
contribution of medium to the stimulation.
Supplementary material related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.vetimm.2013.06.015.
At the end of the study period, subclinical animals were
subjected to pathological and bacteriological investigations
to determine their infection or disease status with respect
to Map. A summary of this information including breed and
age is given in Table 2.
Histological examination of lymph nodes and intestine
samples from eight subclinical sheep was carried out. Three
had lesions previously described as paucibacillary (PC212,
P7, 4349) and samples of their ileum and lymph nodes
showed a severe infiltrate of small lymphocytes and multi-
focal small granulomata, with multinucleated giant cells.
In animals where macroscopic nodules were observed,
some of these granulomata were encapsulated and showed
evidence of calcification (Fig. 2B). ZN staining of these
samples did not show any acid-fast organisms. Macro-
scopic observations of the gastrointestinal tract showed
enlarged lymph nodes in two animals (PC212 and 4349)
and widespread formation of small, round, 1–2 mm diam-
eter nodules on the surface of the small intestine and
lymph nodes of two sheep (P7 and 4349) (Fig. 2A). One
had lesions consistent with multibacillary JD (P15) (Fig. 2C
and D), changes in the ileum were characterised by sheets
of closely packed macrophages with abundant, weakly
eosinophilic cytoplasm, mainly seen in the mucosa. A
milder similar infiltrate was  observed in the lamina propria,
submucosa and in the lymph nodes. ZN staining demon-
strated a large number of acid-fast rods in the cytoplasm
of macrophages (Fig. 2D). Two further animals (0269 and
W395) had an inflammatory infiltrate characterised by
large amounts of eosinophils, some neutrophils and small
mineralised abscesses. The samples from the remaining
two animals (W363 and P33) were within normal his-
tological limits (Table 2). The significance of the small,
mineralised nodules observed macroscopically on the sur-
face and within the tissues was difficult to determine.
Similar lesions were reported previously in JD, but were
attributed to parasitic infection (Pérez et al., 1996). How-
ever, the cases described here had low parasitic loads and
an absence of parasitic debris. Mineralisation of lymph
node lesions has been described previously in JD-affected
wild ruminants (Williams et al., 1983; de Lisle et al.,
1993) so it is not implausible that the mineralised nodules
observed in this study were pathological lesions of JD.
Animal PC212 was one of the higher producers of
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Table 2
Summary of the post mortem pathological and bacteriological observations in the subclinical animals.
W363♀ PC212♀ P7♀ 4349♀b 0269♀ W395♀ P33♀ P15a♀
General condition Good Good, but thin Good, but
moderately
thin
Good Good Good Good Scouring and very thin
FEC  0 0 0 0 0 0 0 High (6750/g)












Bleu du Maine X Lleyn X
Age  (yrs) at PM/death 8 8 7 6 7 6 5 3.5







on surface of GI
tract, ICLN &
MLN  and liver
Some
cysts/nodules
on surface of GI
tract, ICLN,
MLN  & liver
MLN  enlarged
with single cyst
GI tract, ICLN &
MLN appeared
normal
GI tract, ICLN &
MLN appeared
normal
























































in the IM or LN.
Inflammatory infiltrate





Map  isolated from tissues No +TI, ICLN +TI, MLN, ICLN +TI, MLN  No No No NDc





FEC, faecal egg count; Strongylata, Nematodirus and Coccidia were identified in faecal material; TI, terminal Ileum; IM,  ileal mucosa; ISM, ileal submuscosa; LN, lymph node; DJ, distal jejunum; ICLN, ileo-caecal
lymph  node; ICV, ileo-caecal valve; MLN, mesenteric lymph node.
a Died.
b Animal recruited late to study and not used for screening recombinant antigens.
c Not done, however,large numbers of acid fast bacilli were noted in IM,  ISM and LN and faeces was  culture positive for Map.
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Fig. 2. (A) Ileum of sheep P7 showing macroscopical widespread 1–2 mm diameter nodules and microscopical encapsulated granuloma (B) with numerous
multinucleated giant cells and calcification (H&E, original magnification ×200). (C) Multibacillary paratuberculosis (P15): very large number of macrophages
with  abundant cytoplasm infiltrating ileal mucosa (H&E, original magnification ×200) and (D) stained with ZN (original magnification ×200).
of antibody. This case shows that high levels of anti-
body can exist alongside a well developed Th1 response,
which goes against the dogma of the switch hypothesis
(Chiodini et al., 1984; Stabel, 2000, 2006) and supports the
temporally coincident antibody/IFN-  responses for some
animals with JD as previously reported (Begg et al., 2011).
The ability of these proteins to discriminate between
subclinical and control animals indicates their potential as
diagnostic tools in IGRAs for the detection of subclinical
infections in sheep and their identification is a step towards
a better diagnostic tool for JD. The mean OD values of all
antigens were lower than that obtained for PPDj stimula-
tion of the infected group (0.7) which indicates that the
complex antigenic mix  of PPDj was a more powerful stim-
ulant of IFN- production than any of the recombinant anti-
gens. However, a mixture of the three antigens in a single
IGRA increased the magnitude of response and was  effec-
tively the sum of the individual parts (authors unpublished
observations). This indicates that cocktails of recombi-
nant proteins maybe necessary to develop future sensitive
diagnostic tests. Although specificity of these proteins is
implied, an empirical approach to test the specificity of an
IGRA incorporating these proteins is still required.
The application of the IFN- test for detection of indi-
vidual animals likely to progress to clinical disease is still
debatable. Global differences of IFN- response to PPD in
exposed and non-exposed populations was clearly demon-
strated (Jungersen et al., 2012), but its ability to predict
shedding or clinical disease in individual animals was  not
(Huda et al., 2004; Mikkelsen et al., 2009). In our study, four
out of eight sheep with elevated IFN- release (in excess of
400 pg/ml) either had a positive diagnosis of paratubercu-
losis as defined by the serum antibody ELISA or progressed
to it within the time scale of the experiment (2–3 years).
This high proportion of IGRA test positive animals which
progressed to diagnosis by the classical serum ELISA test
appears to be at odds with previous findings (Huda et al.,
2004). The likelihood of an exposed animal (as defined
by IFN- response) developing detectable infection (either
faecal shedding or a positive serum ELISA test) and the
impact of external factors is yet to be defined and crucial for
determining the efficacy of the IGRA to act as a prognostic
for JD.
A major drawback in control and eradication of JD is the
lack of tools to identify early-stage infections. Generation of
tools to monitor exposure of individual animals to Map  may
provide a starting point to understand disease progression
and in ovine cases, may  have applications in indicating ani-
mals which should be removed from flocks to control the
spread of disease.
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